nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.000289	CcSEcCtD
Ganciclovir—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000288	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Ganciclovir—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Ganciclovir—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000287	0.000287	CcSEcCtD
Ganciclovir—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000286	CcSEcCtD
Ganciclovir—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000285	0.000285	CcSEcCtD
Ganciclovir—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000285	0.000285	CcSEcCtD
Ganciclovir—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Ganciclovir—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000284	0.000284	CcSEcCtD
Ganciclovir—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000283	0.000283	CcSEcCtD
Ganciclovir—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000282	CcSEcCtD
Ganciclovir—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000281	CcSEcCtD
Ganciclovir—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000281	CcSEcCtD
Ganciclovir—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000281	0.000281	CcSEcCtD
Ganciclovir—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.00028	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Ganciclovir—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Ganciclovir—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000278	0.000278	CcSEcCtD
Ganciclovir—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000277	CcSEcCtD
Ganciclovir—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Ganciclovir—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000276	0.000276	CcSEcCtD
Ganciclovir—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000275	CcSEcCtD
Ganciclovir—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000274	CcSEcCtD
Ganciclovir—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000274	CcSEcCtD
Ganciclovir—Pain—Etoposide—peripheral nervous system neoplasm	0.000273	0.000273	CcSEcCtD
Ganciclovir—Constipation—Etoposide—peripheral nervous system neoplasm	0.000273	0.000273	CcSEcCtD
Ganciclovir—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000273	CcSEcCtD
Ganciclovir—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000273	CcSEcCtD
Ganciclovir—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000272	CcSEcCtD
Ganciclovir—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000272	CcSEcCtD
Ganciclovir—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000271	CcSEcCtD
Ganciclovir—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.000271	CcSEcCtD
Ganciclovir—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00027	0.00027	CcSEcCtD
Ganciclovir—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000269	0.000269	CcSEcCtD
Ganciclovir—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000269	CcSEcCtD
Ganciclovir—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000268	CcSEcCtD
Ganciclovir—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000266	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000265	0.000265	CcSEcCtD
Ganciclovir—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000264	0.000264	CcSEcCtD
Ganciclovir—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Ganciclovir—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000263	0.000263	CcSEcCtD
Ganciclovir—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000262	0.000262	CcSEcCtD
Ganciclovir—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000262	CcSEcCtD
Ganciclovir—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000261	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000261	0.000261	CcSEcCtD
Ganciclovir—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000261	0.000261	CcSEcCtD
Ganciclovir—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00026	0.00026	CcSEcCtD
Ganciclovir—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.00026	CcSEcCtD
Ganciclovir—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.00026	CcSEcCtD
Ganciclovir—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.000258	CcSEcCtD
Ganciclovir—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.000258	CcSEcCtD
Ganciclovir—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Ganciclovir—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000257	0.000257	CcSEcCtD
Ganciclovir—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000256	0.000256	CcSEcCtD
Ganciclovir—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000255	CcSEcCtD
Ganciclovir—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000255	CcSEcCtD
Ganciclovir—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000254	0.000254	CcSEcCtD
Ganciclovir—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000253	CcSEcCtD
Ganciclovir—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000253	CcSEcCtD
Ganciclovir—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000253	CcSEcCtD
Ganciclovir—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000253	CcSEcCtD
Ganciclovir—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Ganciclovir—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Ganciclovir—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Ganciclovir—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Ganciclovir—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Ganciclovir—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000252	CcSEcCtD
Ganciclovir—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000251	CcSEcCtD
Ganciclovir—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000251	0.000251	CcSEcCtD
Ganciclovir—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00025	0.00025	CcSEcCtD
Ganciclovir—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00025	0.00025	CcSEcCtD
Ganciclovir—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.000249	CcSEcCtD
Ganciclovir—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000249	0.000249	CcSEcCtD
Ganciclovir—Rash—Vincristine—peripheral nervous system neoplasm	0.000249	0.000249	CcSEcCtD
Ganciclovir—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Ganciclovir—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Ganciclovir—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Ganciclovir—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000248	CcSEcCtD
Ganciclovir—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000247	CcSEcCtD
Ganciclovir—Headache—Vincristine—peripheral nervous system neoplasm	0.000247	0.000247	CcSEcCtD
Ganciclovir—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000246	CcSEcCtD
Ganciclovir—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000243	0.000243	CcSEcCtD
Ganciclovir—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000243	CcSEcCtD
Ganciclovir—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.000242	CcSEcCtD
Ganciclovir—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Ganciclovir—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000238	0.000238	CcSEcCtD
Ganciclovir—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000235	0.000235	CcSEcCtD
Ganciclovir—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000235	CcSEcCtD
Ganciclovir—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000234	CcSEcCtD
Ganciclovir—Nausea—Vincristine—peripheral nervous system neoplasm	0.000234	0.000234	CcSEcCtD
Ganciclovir—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000234	CcSEcCtD
Ganciclovir—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000233	CcSEcCtD
Ganciclovir—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.000233	CcSEcCtD
Ganciclovir—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000232	CcSEcCtD
Ganciclovir—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000231	CcSEcCtD
Ganciclovir—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.00023	CcSEcCtD
Ganciclovir—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.00023	CcSEcCtD
Ganciclovir—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000229	0.000229	CcSEcCtD
Ganciclovir—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000229	CcSEcCtD
Ganciclovir—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000229	CcSEcCtD
Ganciclovir—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000229	CcSEcCtD
Ganciclovir—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000227	0.000227	CcSEcCtD
Ganciclovir—Chills—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Ganciclovir—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000226	0.000226	CcSEcCtD
Ganciclovir—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000225	CcSEcCtD
Ganciclovir—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000225	CcSEcCtD
Ganciclovir—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000223	CcSEcCtD
Ganciclovir—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000222	0.000222	CcSEcCtD
Ganciclovir—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000221	CcSEcCtD
Ganciclovir—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00022	CcSEcCtD
Ganciclovir—Rash—Cisplatin—peripheral nervous system neoplasm	0.00022	0.00022	CcSEcCtD
Ganciclovir—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00022	0.00022	CcSEcCtD
Ganciclovir—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000219	CcSEcCtD
Ganciclovir—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000218	0.000218	CcSEcCtD
Ganciclovir—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000217	CcSEcCtD
Ganciclovir—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000216	CcSEcCtD
Ganciclovir—Tension—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000215	CcSEcCtD
Ganciclovir—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000215	CcSEcCtD
Ganciclovir—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000213	CcSEcCtD
Ganciclovir—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000212	CcSEcCtD
Ganciclovir—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000212	CcSEcCtD
Ganciclovir—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000211	0.000211	CcSEcCtD
Ganciclovir—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000211	CcSEcCtD
Ganciclovir—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.00021	CcSEcCtD
Ganciclovir—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000209	CcSEcCtD
Ganciclovir—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000208	CcSEcCtD
Ganciclovir—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000207	0.000207	CcSEcCtD
Ganciclovir—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000207	CcSEcCtD
Ganciclovir—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000206	CcSEcCtD
Ganciclovir—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000204	CcSEcCtD
Ganciclovir—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000204	CcSEcCtD
Ganciclovir—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000203	0.000203	CcSEcCtD
Ganciclovir—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.000203	CcSEcCtD
Ganciclovir—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000203	CcSEcCtD
Ganciclovir—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000202	CcSEcCtD
Ganciclovir—Rash—Etoposide—peripheral nervous system neoplasm	0.000201	0.000201	CcSEcCtD
Ganciclovir—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000201	0.000201	CcSEcCtD
Ganciclovir—Headache—Etoposide—peripheral nervous system neoplasm	0.0002	0.0002	CcSEcCtD
Ganciclovir—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.0002	CcSEcCtD
Ganciclovir—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000199	CcSEcCtD
Ganciclovir—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000199	CcSEcCtD
Ganciclovir—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000198	CcSEcCtD
Ganciclovir—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000197	CcSEcCtD
Ganciclovir—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000197	CcSEcCtD
Ganciclovir—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000196	CcSEcCtD
Ganciclovir—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000196	CcSEcCtD
Ganciclovir—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000195	CcSEcCtD
Ganciclovir—Cough—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000191	CcSEcCtD
Ganciclovir—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000191	CcSEcCtD
Ganciclovir—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.00019	0.00019	CcSEcCtD
Ganciclovir—Nausea—Etoposide—peripheral nervous system neoplasm	0.00019	0.00019	CcSEcCtD
Ganciclovir—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000189	0.000189	CcSEcCtD
Ganciclovir—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000188	CcSEcCtD
Ganciclovir—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000188	CcSEcCtD
Ganciclovir—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000187	CcSEcCtD
Ganciclovir—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000187	CcSEcCtD
Ganciclovir—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000187	CcSEcCtD
Ganciclovir—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000186	CcSEcCtD
Ganciclovir—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000186	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000185	CcSEcCtD
Ganciclovir—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000184	CcSEcCtD
Ganciclovir—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000183	0.000183	CcSEcCtD
Ganciclovir—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000183	CcSEcCtD
Ganciclovir—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000182	CcSEcCtD
Ganciclovir—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000182	CcSEcCtD
Ganciclovir—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.00018	0.00018	CcSEcCtD
Ganciclovir—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000179	CcSEcCtD
Ganciclovir—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000179	CcSEcCtD
Ganciclovir—Infection—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000178	CcSEcCtD
Ganciclovir—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000177	CcSEcCtD
Ganciclovir—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000176	CcSEcCtD
Ganciclovir—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000175	CcSEcCtD
Ganciclovir—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000175	CcSEcCtD
Ganciclovir—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000175	0.000175	CcSEcCtD
Ganciclovir—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000174	0.000174	CcSEcCtD
Ganciclovir—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000173	CcSEcCtD
Ganciclovir—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000173	CcSEcCtD
Ganciclovir—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000173	CcSEcCtD
Ganciclovir—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000173	CcSEcCtD
Ganciclovir—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000172	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000172	CcSEcCtD
Ganciclovir—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000171	CcSEcCtD
Ganciclovir—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000171	CcSEcCtD
Ganciclovir—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000169	CcSEcCtD
Ganciclovir—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000167	0.000167	CcSEcCtD
Ganciclovir—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000167	CcSEcCtD
Ganciclovir—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000166	CcSEcCtD
Ganciclovir—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000166	CcSEcCtD
Ganciclovir—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000165	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000163	CcSEcCtD
Ganciclovir—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000162	CcSEcCtD
Ganciclovir—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000162	CcSEcCtD
Ganciclovir—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000162	CcSEcCtD
Ganciclovir—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000161	CcSEcCtD
Ganciclovir—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000161	CcSEcCtD
Ganciclovir—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.00016	CcSEcCtD
Ganciclovir—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00016	CcSEcCtD
Ganciclovir—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000159	CcSEcCtD
Ganciclovir—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000158	CcSEcCtD
Ganciclovir—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000158	CcSEcCtD
Ganciclovir—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000156	CcSEcCtD
Ganciclovir—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000155	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000155	CcSEcCtD
Ganciclovir—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000154	CcSEcCtD
Ganciclovir—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000153	CcSEcCtD
Ganciclovir—Pain—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000153	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000151	CcSEcCtD
Ganciclovir—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00015	CcSEcCtD
Ganciclovir—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000149	CcSEcCtD
Ganciclovir—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000148	CcSEcCtD
Ganciclovir—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000148	CcSEcCtD
Ganciclovir—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000147	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000146	CcSEcCtD
Ganciclovir—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000146	CcSEcCtD
Ganciclovir—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000144	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000143	CcSEcCtD
Ganciclovir—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000143	CcSEcCtD
Ganciclovir—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000142	CcSEcCtD
Ganciclovir—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000142	CcSEcCtD
Ganciclovir—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000142	CcSEcCtD
Ganciclovir—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000142	CcSEcCtD
Ganciclovir—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000142	CcSEcCtD
Ganciclovir—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000136	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000135	CcSEcCtD
Ganciclovir—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000132	CcSEcCtD
Ganciclovir—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000132	CcSEcCtD
Ganciclovir—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000131	CcSEcCtD
Ganciclovir—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000131	CcSEcCtD
Ganciclovir—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000128	CcSEcCtD
Ganciclovir—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000127	CcSEcCtD
Ganciclovir—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000122	CcSEcCtD
Ganciclovir—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000122	CcSEcCtD
Ganciclovir—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000119	CcSEcCtD
Ganciclovir—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000118	CcSEcCtD
Ganciclovir—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000117	CcSEcCtD
Ganciclovir—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000114	CcSEcCtD
Ganciclovir—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000113	CcSEcCtD
Ganciclovir—Rash—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000113	CcSEcCtD
Ganciclovir—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000113	CcSEcCtD
Ganciclovir—Headache—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000112	CcSEcCtD
Ganciclovir—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00011	CcSEcCtD
Ganciclovir—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000106	CcSEcCtD
Ganciclovir—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000105	CcSEcCtD
Ganciclovir—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000104	CcSEcCtD
Ganciclovir—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000104	CcSEcCtD
Ganciclovir—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000104	CcSEcCtD
Ganciclovir—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.84e-05	9.84e-05	CcSEcCtD
